CAG
HSTO

Curtis Advisory Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Curtis Advisory Group’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-717
Closed -$19K – 76
2021
Q1 		$19K Buy
+717
New +$18K 0.01% 74

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Curtis Advisory Group's HSTO Position: Q2 2021 in Review

Curtis Advisory Group sold out of Histogen Inc. Common Stock (HSTO) in Q2 2021, closing a stake of 717 shares — an estimated $19K sold.

Curtis Advisory Group first reported a position in HSTO in Q1 2021 and held it in 1 quarter. The position peaked at $19K in Q1 2021. 24 funds tracked by Wall St. Rank hold HSTO as of Q2 2021.

  • Curtis Advisory Group reported no remaining Histogen Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Curtis Advisory Group sold 717 Histogen Inc. Common Stock shares in Q2 2021, an estimated $19K.
  • Curtis Advisory Group first reported a position in Histogen Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Curtis Advisory Group's Histogen Inc. Common Stock position peaked at $19K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2021.

Based on Curtis Advisory Group's 13F filing for Q2 2021, filed 27 Jul 2021.